title: Finasteride for recurrent priapism in children and adolescents: a report on 5 cases.
abstract: OBJECTIVE
  Recurrent priapism is prevalent in children. Different medications have been used to avoid new episodes, however, there is no consensus regarding the best option. The use of finasteride to treat priapism in adults has already been tested. The aim of the present study was to test the hypothesis that a low dose of finasteride would be effective in preventing recurrent priapism in children.
  
  
  METHODS
  Since 2007, five children and adolescents with recurrent episodes of priapism have been treated with finasteride in our department, and the medical records of these patients were reviewed for this study. In four cases, the dose used was 1 mg a day, while the remaining patient used 1 mg twice a day.
  
  
  RESULTS
  Prior to initiating finasteride treatment, one patient reported having had 6 episodes of acute priapism, while the remaining patients had more than 10 episodes. One of the patients reported having stuttering priapism almost daily. With a mean follow-up of 20 months, four patients had no episodes and only one patient complained of sporadic and shorter duration episodes.
  
  
  CONCLUSIONS
  These initial results suggest that a low daily dose of finasteride appears to represent an effective and safe form of treatment for recurrent priapism in children and adolescents with SCD. However, in order to confirm these initial findings, studies with a large population and a control group are essential.
authors.affiliation: Escola Bahiana de Medicina e Saude Publica, BA, Brazil. ubarroso@uol.com.br
authors.forename: Ubirajara
authors.initials: U
authors.lastname: Barroso
authors.forename: Thamy C S
authors.initials: TC
authors.lastname: Marques
authors.forename: Hugo F F
authors.initials: HF
authors.lastname: Novaes
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000008:administration & dosage*; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D018120:Finasteride / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011317:Priapism / Q000188:drug therapy*; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D058891:5-alpha Reductase Inhibitors; D018120:Finasteride